Latest News and Press Releases
Want to stay updated on the latest news?
-
SAN DIEGO, CA--(Marketwired - Jun 19, 2013) - In Association of Molecular Pathology v. Myriad, the U.S. Supreme Court struck down BRCA1 and BRCA2 gene patent claims. It is important for the...
-
SAN DIEGO, CA--(Marketwired - May 14, 2013) - Los Laboratorios MLL Münchner Leukämielabor GmbH ("MLL") fueron hallados culpables de infringimiento de patente en una cuestión que...
-
SAN DIEGO, CA--(Marketwired - May 14, 2013) - Die MLL Münchner Leukämielabor GmbH ("MLL") Laboratorien wurden der Verletzung von Patentrechten bezüglich FLT3 Mutationstests, für...
-
SAN DIEGO, CA--(Marketwired - May 14, 2013) - MLL Münchner Leukämielabor GmbH ("MLL") Laboratories foi julgado culpado na ação que envolve os direitos de patente de teste de...
-
SAN DIEGO, CA--(Marketwired - May 14, 2013) - MLL Münchner Leukämielabor GmbH ("MLL") Laboratories has been found guilty of patent infringement in a matter involving FLT3 testing patent...
-
SAN DIEGO, CA--(Marketwire - Dec 5, 2012) - Invivoscribe Technologies, Inc. (San Diego, California) aanunció hoy que ha celebrado un acuerdo con Takara Bio Inc. (Otsu, Shiga, Japón)...
-
SAN DIEGO, CA--(Marketwire - Dec 5, 2012) - A Invivoscribe Technologies, Inc. (San Diego, Califórnia) anunciou hoje um acordo com a Takara Bio, Inc. (Otsu, Shiga, Japão) com o qual ela...
-
SAN DIEGO, CA--(Marketwire - Dec 5, 2012) - Invivoscribe Technologies, Inc. (San Diego, California) announced today that it has entered into an agreement with Takara Bio, Inc. (Otsu, Shiga, Japan)...
-
SAN DIEGO, CA--(Marketwire - Dec 4, 2012) - Invivoscribe Technologies, Inc., una compañía privada de ciencias biológicas basada en San Diego, California, anuncia el lanzamiento de...
-
SAN DIEGO, CA--(Marketwire - Dec 4, 2012) - A Invivoscribe Technologies, Inc., uma empresa privada de ciências da vida de San Diego, Califórnia, anuncia o lançamento da Genection,...